Modulation of afferent nerve activity by prostaglandin E2 upon urinary bladder distension in rats

被引:10
|
作者
Kuga, Nahoko [1 ]
Tanioka, Asao [1 ]
Hagihara, Koichiro [1 ]
Kawai, Tomoyuki [1 ]
机构
[1] Kyorin Pharmaceut Co Ltd, Watarase Res Ctr, 1848 Nogi, Nogi, Tochigi, Japan
关键词
GROWTH-FACTOR; VISCERAL AFFERENTS; BOTULINUM-TOXIN; FIBERS; OVERACTIVITY; NEURONS; SENSITIZATION; CONTRACTIONS; INFLAMMATION; OXYBUTYNIN;
D O I
10.1113/EP085418
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
In overactive bladder syndrome, afferent C fibres innervating the bladder show an increased activity level. However, it remains unclear whether all C fibres are highly activated and whether A delta fibres, the other type of bladder afferent fibre, are also involved in pathological conditions. To address these questions, we analysed the relationship between bladder pressure and single-unit firing patterns of afferent nerves in the left L6 dorsal roots in living rats. The recorded fibres were classified as A delta fibres or C fibres based on the response to 0.3 mu m tetrodotoxin. Certain populations of both A delta fibres and C fibres were activated at bladder pressures below 15 cm H2O (classified as low-threshold fibres), indicating their potential contribution to detection of normal bladder filling. Intravesical administration of prostaglandin E-2 (PGE(2)) induced hyperexcitation in approximately half of such C fibres, whereas the activity patterns of low-threshold A delta fibres were unchanged. All fibres, regardless of type, which were almost silent in control conditions (classified as high-threshold fibres), were activated by application of PGE(2). Notably, the firing patterns of A delta fibres, rather than C fibres, were highly time locked to PGE(2)-induced micro-oscillation of bladder pressure. Thesemodulatory effects of PGE(2) on A delta fibres and C fibres might trigger pathophysiological activity together in overactive bladder syndrome.
引用
收藏
页码:577 / 587
页数:11
相关论文
共 50 条
  • [31] Urinary Prostaglandin E2 Was Increased in Patients With Suprapontine Brain Diseases, and Associated With Overactive Bladder Syndrome
    Yamauchi, Hiroki
    Akino, Hironobu
    Ito, Hideaki
    Aoki, Yoshitaka
    Nomura, Tadao
    Yokoyama, Osamu
    UROLOGY, 2010, 76 (05) : 1267.e13 - 1267.e19
  • [32] THR expression of prostaglandin E2 receptors (EP1, 2, 3, and 4) in the human urinary bladder epithelium of normal and bladder outlet obstruction. A novel mechanism in the afferent hyperactivity of bladder
    Yuanjun, Jiang
    Kobayashi, Hideki
    Sawada, Norifumi
    Yoshiyama, Mitsuharu
    Mochizuki, Tsutomu
    Zakoji, Hidenori
    Araki, Isao
    Takeda, Masayuki
    JOURNAL OF UROLOGY, 2008, 179 (04): : 452 - 452
  • [33] POTENTIAL BIOMARKERS FOR DIAGNOSIS AND PREDICTION OF TREATMENT EFFICACY IN OVERACTIVE BLADDER PATIENTS: URINARY NERVE GROWTH FACTOR, PROSTAGLANDIN E2, AND ADENOSINE TRIPHOSPHATE
    Suh, Y. S.
    Kim, T. H.
    Sung, H. H.
    Choo, M.
    Lee, K.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S406 - S407
  • [34] CHANGES IN URINARY PROSTAGLANDIN E2 EXCRETION IN WATANABE HERITABLE HYPERLIPIDEMIC RABBITS, A BLADDER ISCHEMIA MODEL
    Yoshida, M.
    Masunaga, K.
    Satoji, Y.
    Maeda, Y.
    Nagata, T.
    Inadome, A.
    NEUROUROLOGY AND URODYNAMICS, 2009, 28 (07) : 704 - 704
  • [35] Role of Proinflammatory Prostaglandin E2 in Bladder Tumor Progression
    Hara, Shuntaro
    NEW TRENDS IN THE MOLECULAR AND BIOLOGICAL BASIS FOR CLINICAL ONCOLOGY, 2009, : 92 - 95
  • [36] Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers
    Gross, ND
    Boyle, JO
    Morrow, JD
    Williams, MK
    Moskowitz, CS
    Subbaramaiah, K
    Dannenberg, AJ
    Duffield-Lillico, AJ
    CLINICAL CANCER RESEARCH, 2005, 11 (16) : 6087 - 6093
  • [37] STRUCTURE OF MAJOR URINARY METABOLITE OF PROSTAGLANDIN E2 IN MAN
    HAMBERG, M
    SAMUELSSON, B
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1969, 91 (08) : 2177 - +
  • [38] Urinary Prostaglandin E2 Metabolite and Breast Cancer Risk
    Cui, Yong
    Shu, Xiao-Ou
    Gao, Yu-Tang
    Cai, Qiuyin
    Ji, Bu-Tian
    Li, Hong-Lan
    Rothman, Nathaniel
    Wu, Jie
    Yang, Gong
    Xiang, Yong-Bing
    Zheng, Wei
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (12) : 2866 - 2873
  • [39] STRUCTURE OF A URINARY METABOLITE OF PROSTAGLANDIN E2 IN GUINEA PIG
    HAMBERG, M
    SAMUELSSON, B
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1969, 34 (01) : 22 - +
  • [40] Urinary Prostaglandin E2 Metabolite and Risk for Colorectal Adenoma
    Shrubsole, Martha J.
    Cai, Qiuyin
    Wen, Wanqing
    Milne, Ginger
    Smalley, Walter E.
    Chen, Zhi
    Ness, Reid M.
    Zheng, Wei
    CANCER PREVENTION RESEARCH, 2012, 5 (02) : 336 - 342